FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
![]() |
#1 | |||
|
||||
Grand Magnate
|
AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS) at the European Network for the Cure of ALS (ENCALS) annual meeting
Study was a success showing masitinib to be a safe and effective treatment in ALS AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS) at the European Network for the Cure of ALS (ENCALS) annual meeting Paris Stock Exchange:AB.PA |
|||
![]() |
![]() |
Reply |
Thread Tools | |
Display Modes | |
|
|
![]() |
||||
Thread | Forum | |||
Brainstorm Cell Therapeutics Set To Begin Phase 3 In Amyotrophic Lateral Sclerosis | ALS News & Research | |||
New Treatment for Amyotrophic Lateral Sclerosis Passes Phase III Trials | ALS News & Research | |||
AB Science Reports Positive Interim Results in Phase 3 Trial of Masitinib as an ALS | ALS News & Research | |||
Understanding the Causes of Amyotrophic Lateral Sclerosis | ALS News & Research | |||
A Symposium on Amyotrophic Lateral Sclerosis | ALS News & Research |